Novartis Plans to Align its Production with Expected Lower Prices in the US

 Novartis Plans to Align its Production with Expected Lower Prices in the US

Novartis Plans to Align its Production with Expected Lower Prices in the US

Shots:
  • Novartis plans to increase its worldwide operating profit margins by making production efficient, in spite of dipping in prices for its drugs in the US
  • The company aims to increase efficiency of pharma business from 32% to 35% within five years
  • As per Novartis chairman, drug prices are rising in Europe and Novartis can charge slightly higher or stable prices in Europe
Click here to read full press release/ article | Ref: Reuters | Image:  Novartis

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post